The protective effects of statins in traumatic brain injury
Pharmacol Rep. 2024 Mar 7. doi: 10.1007/s43440-024-00582-9. Online ahead of print.ABSTRACTTraumatic brain injury (TBI), often referred to as the "silent epidemic", is the most common cause of mortality and morbidity worldwide among all trauma-related injuries. It is associated with considerable personal, medical, and economic consequences. Although remarkable advances in therapeutic approaches have been made, current treatments and clinical management for TBI recovery still remain to be improved. One of the factors that may contribute to this gap is that existing therapies target only a single event or pathology. However, ...
Source: Pharmacological Reports - March 6, 2024 Category: Drugs & Pharmacology Authors: Safoora Pordel Alice P McCloskey Wael Almahmeed Amirhossein Sahebkar Source Type: research
The protective effects of statins in traumatic brain injury
Pharmacol Rep. 2024 Mar 7. doi: 10.1007/s43440-024-00582-9. Online ahead of print.ABSTRACTTraumatic brain injury (TBI), often referred to as the "silent epidemic", is the most common cause of mortality and morbidity worldwide among all trauma-related injuries. It is associated with considerable personal, medical, and economic consequences. Although remarkable advances in therapeutic approaches have been made, current treatments and clinical management for TBI recovery still remain to be improved. One of the factors that may contribute to this gap is that existing therapies target only a single event or pathology. However, ...
Source: Pharmacological Reports - March 6, 2024 Category: Drugs & Pharmacology Authors: Safoora Pordel Alice P McCloskey Wael Almahmeed Amirhossein Sahebkar Source Type: research
The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations
This article attempts to address these questions by summarizing the knowledge accumulated in this field over the last three decades.PMID:38438661 | DOI:10.1007/s43440-024-00576-7 (Source: Pharmacological Reports)
Source: Pharmacological Reports - March 4, 2024 Category: Drugs & Pharmacology Authors: Magdalena Boncler Jacek Gola ński Source Type: research
The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations
This article attempts to address these questions by summarizing the knowledge accumulated in this field over the last three decades.PMID:38438661 | DOI:10.1007/s43440-024-00576-7 (Source: Pharmacological Reports)
Source: Pharmacological Reports - March 4, 2024 Category: Drugs & Pharmacology Authors: Magdalena Boncler Jacek Gola ński Source Type: research
The study of platelet aggregation using a microtiter plate reader ‒ methodological considerations
This article attempts to address these questions by summarizing the knowledge accumulated in this field over the last three decades.PMID:38438661 | DOI:10.1007/s43440-024-00576-7 (Source: Pharmacological Reports)
Source: Pharmacological Reports - March 4, 2024 Category: Drugs & Pharmacology Authors: Magdalena Boncler Jacek Gola ński Source Type: research
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids
CONCLUSIONS: There were considerable differences in OUD symptom patterns and substance use treatment among individuals who misused opioids. The findings indicate a substantial unmet need for OUD treatment and point to patterns of heterogeneity within OUD that can inform development of treatment programs.PMID:38414666 | PMC:PMC10897812 | DOI:10.1016/j.dadr.2024.100220 (Source: Pharmacological Reports)
Source: Pharmacological Reports - February 28, 2024 Category: Drugs & Pharmacology Authors: Emily A Miller Angela M DeVeaugh-Geiss Howard D Chilcoat Source Type: research
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids
CONCLUSIONS: There were considerable differences in OUD symptom patterns and substance use treatment among individuals who misused opioids. The findings indicate a substantial unmet need for OUD treatment and point to patterns of heterogeneity within OUD that can inform development of treatment programs.PMID:38414666 | PMC:PMC10897812 | DOI:10.1016/j.dadr.2024.100220 (Source: Pharmacological Reports)
Source: Pharmacological Reports - February 28, 2024 Category: Drugs & Pharmacology Authors: Emily A Miller Angela M DeVeaugh-Geiss Howard D Chilcoat Source Type: research
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids
CONCLUSIONS: There were considerable differences in OUD symptom patterns and substance use treatment among individuals who misused opioids. The findings indicate a substantial unmet need for OUD treatment and point to patterns of heterogeneity within OUD that can inform development of treatment programs.PMID:38414666 | PMC:PMC10897812 | DOI:10.1016/j.dadr.2024.100220 (Source: Pharmacological Reports)
Source: Pharmacological Reports - February 28, 2024 Category: Drugs & Pharmacology Authors: Emily A Miller Angela M DeVeaugh-Geiss Howard D Chilcoat Source Type: research
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids
CONCLUSIONS: There were considerable differences in OUD symptom patterns and substance use treatment among individuals who misused opioids. The findings indicate a substantial unmet need for OUD treatment and point to patterns of heterogeneity within OUD that can inform development of treatment programs.PMID:38414666 | PMC:PMC10897812 | DOI:10.1016/j.dadr.2024.100220 (Source: Pharmacological Reports)
Source: Pharmacological Reports - February 28, 2024 Category: Drugs & Pharmacology Authors: Emily A Miller Angela M DeVeaugh-Geiss Howard D Chilcoat Source Type: research
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids
CONCLUSIONS: There were considerable differences in OUD symptom patterns and substance use treatment among individuals who misused opioids. The findings indicate a substantial unmet need for OUD treatment and point to patterns of heterogeneity within OUD that can inform development of treatment programs.PMID:38414666 | PMC:PMC10897812 | DOI:10.1016/j.dadr.2024.100220 (Source: Pharmacological Reports)
Source: Pharmacological Reports - February 28, 2024 Category: Drugs & Pharmacology Authors: Emily A Miller Angela M DeVeaugh-Geiss Howard D Chilcoat Source Type: research
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
Pharmacol Rep. 2024 Feb 22. doi: 10.1007/s43440-024-00568-7. Online ahead of print.ABSTRACTRenal cell carcinoma (RCC) arises from the tubular epithelial cells of the nephron. It has the highest mortality rate among urological cancers. There are no effective therapeutic approaches and no non-invasive biomarkers for diagnosis and follow-up. Thus, suitable novel biomarkers and therapeutic targets are essential for improving RCC diagnosis/prognosis and treatment. Circulating exosomes such as exosomal microRNAs (Exo-miRs) provide non-invasive prognostic/diagnostic biomarkers and valuable therapeutic targets, as they can be easi...
Source: Pharmacological Reports - February 22, 2024 Category: Drugs & Pharmacology Authors: Xiaodong Yu Zhongbo Du Pingyu Zhu Bo Liao Source Type: research
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
Pharmacol Rep. 2024 Feb 22. doi: 10.1007/s43440-024-00568-7. Online ahead of print.ABSTRACTRenal cell carcinoma (RCC) arises from the tubular epithelial cells of the nephron. It has the highest mortality rate among urological cancers. There are no effective therapeutic approaches and no non-invasive biomarkers for diagnosis and follow-up. Thus, suitable novel biomarkers and therapeutic targets are essential for improving RCC diagnosis/prognosis and treatment. Circulating exosomes such as exosomal microRNAs (Exo-miRs) provide non-invasive prognostic/diagnostic biomarkers and valuable therapeutic targets, as they can be easi...
Source: Pharmacological Reports - February 22, 2024 Category: Drugs & Pharmacology Authors: Xiaodong Yu Zhongbo Du Pingyu Zhu Bo Liao Source Type: research
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
Pharmacol Rep. 2024 Feb 22. doi: 10.1007/s43440-024-00568-7. Online ahead of print.ABSTRACTRenal cell carcinoma (RCC) arises from the tubular epithelial cells of the nephron. It has the highest mortality rate among urological cancers. There are no effective therapeutic approaches and no non-invasive biomarkers for diagnosis and follow-up. Thus, suitable novel biomarkers and therapeutic targets are essential for improving RCC diagnosis/prognosis and treatment. Circulating exosomes such as exosomal microRNAs (Exo-miRs) provide non-invasive prognostic/diagnostic biomarkers and valuable therapeutic targets, as they can be easi...
Source: Pharmacological Reports - February 22, 2024 Category: Drugs & Pharmacology Authors: Xiaodong Yu Zhongbo Du Pingyu Zhu Bo Liao Source Type: research
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
Pharmacol Rep. 2024 Feb 22. doi: 10.1007/s43440-024-00568-7. Online ahead of print.ABSTRACTRenal cell carcinoma (RCC) arises from the tubular epithelial cells of the nephron. It has the highest mortality rate among urological cancers. There are no effective therapeutic approaches and no non-invasive biomarkers for diagnosis and follow-up. Thus, suitable novel biomarkers and therapeutic targets are essential for improving RCC diagnosis/prognosis and treatment. Circulating exosomes such as exosomal microRNAs (Exo-miRs) provide non-invasive prognostic/diagnostic biomarkers and valuable therapeutic targets, as they can be easi...
Source: Pharmacological Reports - February 22, 2024 Category: Drugs & Pharmacology Authors: Xiaodong Yu Zhongbo Du Pingyu Zhu Bo Liao Source Type: research
Safety of non-standard regimen of systemic steroid therapy in patients with Graves' orbitopathy: a single-centre experience
CONCLUSIONS: Active GO treatment with high-dose systemic GCs is not associated with serious side effects. Hyperglycemia is the most common steroid-induced complication.PMID:38273183 | PMC:PMC10830746 | DOI:10.1007/s43440-023-00567-0 (Source: Pharmacological Reports)
Source: Pharmacological Reports - January 25, 2024 Category: Drugs & Pharmacology Authors: Nadia Sawicka-Gutaj Dawid Gruszczy ński Natalia Zawalna Kacper Nijakowski Agnieszka Skiba Mateusz Pochylski Jerzy Sowi ński Marek Rucha ła Source Type: research
